<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Nucleophosmin (NPM1) gene has been heavily implicated in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> pathogenesis both as a putative proto-oncogene and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor gene </plain></SENT>
<SENT sid="1" pm="."><plain>NPM1 is the most frequently mutated gene in <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>), while deletion of 5q, where NPM1 maps, is frequent in patients with <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>We have previously shown that mice heterozygous for Npm1 (Npm1+/-) develop a hematologic syndrome with features of human <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Here we analyzed Npm1+/- mutants to determine their susceptibility to <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Npm1+/- mice displayed a greater propensity to develop <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> compared with Npm1+/+ mice </plain></SENT>
<SENT sid="5" pm="."><plain>The Npm1+/- cohort frequently developed <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e> of both myeloid and lymphoid origin with <z:e sem="disease" ids="C0027022" disease_type="Neoplastic Process" abbrv="MPD">myeloid malignancies</z:e> displaying the highest incidence </plain></SENT>
<SENT sid="6" pm="."><plain>Malignant cells retained the <z:mp ids='MP_0002169'>wild-type</z:mp> allele with <z:mpath ids='MPATH_458'>normal</z:mpath> localization and expression of Npm1 at the protein level, suggesting that complete Npm1 loss is not a prerequisite for <z:mp ids='MP_0002006'>tumorigenesis</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain>Our results conclusively demonstrate that Npm1 acts as a haploinsufficient <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor in the hematopoietic compartment </plain></SENT>
</text></document>